WASHINGTON – Federal health officials have moved to put the strongest warning labels on two diabetes drugs, including Avandia, whose possible side effects were the focus of a heated congressional hearing Wednesday accusing the government and drug maker of sitting on information about the health risks. Read More
Comments for: FDA seeks warnings on two diabetes drugs
FDA seeks warnings on two diabetes drugs
You may also like
FDA seeks warnings on two diabetes drugs